Skip to content
x.com路 @ 路 X路路 2026-04-22Score60

RM-055

Reading

KRAS / RAS targeting: from platform to Phase 3

The floor also showed dual ON/OFF (VS-7375) and RM-055, built for amplification and daraxonrasib-resistant models.

Body

Preclinical data on RM-055...Am I having a hallucination? 馃く馃く馃く @RevMedicines #AACR26 #KRAS #Hydrolysis https://t.co/UzTaILEzDv

Heat 97 路 85 likes 路 2 replies 路 10 reposts

Source: x.com 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org